Metraipolis › archive › dc_43d99d53b47b

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial — Europe PMC PMID:41507574

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41507574
DOI
10.1038/s41591-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-06T23:20:57.244Z
SHA-256 of the archived text
ffd9e51bd42f1e04b5787e3f5051b3b9d5104d05e536e6a78e7136fb8a2421de
Stable URL of this page
https://metraipolis.com/documento/dc_43d99d53b47b

How to cite

Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial — Europe PMC PMID:41507574 — Europe PMC (en), https://europepmc.org/article/MED/41507574 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_43d99d53b47b (Metraipolis archive dc_43d99d53b47b, sha256 ffd9e51bd42f1e04b5787e3f5051b3b9d5104d05e536e6a78e7136fb8a2421de)
BibTeX
@misc{dc43d99d53b47b,
  title = {Anti-inflammatory therapy with low-dose IL-2 in acute coronary syndromes: a randomized phase 2 trial — Europe PMC PMID:41507574},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41507574},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_43d99d53b47b; sha256 ffd9e51bd42f1e04b5787e3f5051b3b9d5104d05e536e6a78e7136fb8a2421de},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41507574. Agents can read the archived copy with the MCP tool read_document.